Bleomycin genotoxicity alteration by glutathione and cytochrome P-450 cellular content in respiratory proficient and deficient strains of Saccharomyces cerevisiae

Mutagenesis

Volumn 14, Issue 2, 1999, Pages 233-238

  Poli, Paola ^a   Buschini, Annamaria ^a   Candi, Alessia ^a   Rossi, Carlo ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYTOCHROME P450; DRUG METABOLIZING ENZYME; GLUTATHIONE;

AEROBIC CAPACITY; AGING; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL HYPOXIA; CELL MUTANT; DEGENERATIVE DISEASE; DRUG METABOLISM; GENE CONVERSION; GENOTOXICITY; MITOCHONDRION; MUTAGENIC ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY FUNCTION; SACCHAROMYCES CEREVISIAE;

SACCHAROMYCES CEREVISIAE;

EID: 0033014439     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/14.2.233     Document Type: Article

References (36)

1. Arrick, B.A. and Nathan, C.F. (1984) Glutathione metabolism as a determinant of therapeutic efficacy: a review. Cancer Res., 44, 4224-4232.
2. Barranco, S.C., Townsend, C.M.,Jr. Weintraub, B., Beasley, E.G., MacLean, K.K., Shaeffer, J., Liu, N.H. and Schellenberg, K. (1990) Changes in glutathione content and resistance to anticancer agents in human stomach cancer cells induced by treatments with melphalan in vitro. Cancer Res., 50, 3614-3618.
3. Berthe-Corti, L. Hulsch, R., Nevries, U. and Eckardl-Schupp, F. (1992) Use of batch and fed-batch fermentation for studies on the variation of glutathione content and its influence on the genotoxicity of methyl-nitro-nitrosoguanidine in yeast. Mutagenesis. 7, 25-30.
4. Bianchi, N.O. and López-Larraza, D.M. (1991) DNA damage and repair induced by bleomycin in mammalian and insect cells. Environ. Mol. Mutagen., 17, 63-68.
5. Byrnes, R.W. and Petering, D.H. (1994) DNA strand breakage in isolated nuclei subjected to bleomycin or hydrogen peroxide. Biochem. Pharmacol., 48, 575-582.
6. Chatterjee, A., Jacob-Raman, M. and Mohapatra, B. (1989) Potentiation of bleomycin-induced chromosome aberrations by the radioprotector reduced glutathione. Mutat. Res., 214, 207-213.
7. Chu, K.C., Patel, K.M., Lin, A.H., Tarone, R.E., Linhart, M.S. and Dunkel, V.C. (1981) Evaluating statistical analysis and reproducibility of microbial mutagenicity assays. Mutat. Res., 85, 119-132.
8. Ernster, L., Luft, R. and Orrenius, S. (1995) Mitochondrial diseases. Biochim. Biophys. Acta, 1271, 1-292.
9. Ferguson, L.R. and Turner, P.M. (1988a) 'Petite' mutagenesis by anticancer drugs in Saccharomyces cerevisiae. Eur. J. Cancer Clin. Oncol., 24, 591-596.
10. Ferguson, L.R. and Turner, P.M. (1988b) Mitotic crossing-over by anticancer drugs in Saccharomyces cerevisiae strain D5. Mutat. Res., 204, 239-249.
11. Ferguson, L.R. and von Borstel, R.C. (1992) Induction of the cytoplasmic 'petite' mutation by chemical and physical agents in Saccharomyces cerevisiae. Mutat. Res., 265, 103-148.
12. Garcia-Ruiz, C., Colell, A., Morales, A., Kaplowitz.N. and Fernandez-Checa, J.C. (1995) Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes. Mol. Pharmacol., 48, 825-834.
13. Hannan, M.A. and Nasim, A. (1978) Genetic activity of bleomycin: differential effects on mitotic recombination and mutations in yeast. Mutat. Res., 53, 309-316.
14. Hoffmann, G.R., Quaranta, J.L., Shorter, R.A. and Littlefield, L.G. (1995) Modulation of bleomycin-induced mitotic recombination in yeast by the aminothiols cysteamine and WR-1065. Mol. Gen. Genet., 249, 366-374.
15. Keszenman, D.J., Salvo, V.A. and Nunes, E. (1992) Effects of bleomycin on growth kinetics and survival of Saccharomyces cerevisiae: a model of repair pathways. J. Bacteriol., 174, 3125-3132.
16. Lau, D.H., Lewis, A.D., Ehsan, M.N. and Sikic, B.I. (1991) Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin. Cancer Res., 51, 5181-5187.
17. López-Larraza, D., De Luca, J.C. and Bianchi, N.O. (1990) The kinetics of DNA damage by bleomycin in mammalian cells. Mutat. Res., 232, 57-61.
18. Magni, G.E. and von Borstel, R.C. (1962) Different rates of spontaneous mutation during mitosis and meiosis in yeast. Genetics, 47, 1097-1108.
19. Moore, C.W. (1978) Bleomycin-induced mutation and recombination in Saccharomyces cerevisiae. Mutat. Res., 58, 41-49.
20. Moore, C.W. (1991) Further characterizations of bleomycin-sensitive (blm) mutants of Saccharomyces cerevisiae with implications for a radiomimetic model. J. Bacteriol., 173, 3605-3608.
21. Nagley, P. and Linnane, A.W. (1972) Biogenesis of mitochondria. XXI. Studies on the nature of the mitochondrial genome in yeast: the degenerative effects of ethidium bromide on mitochondrial genetic information in a respiratory competent strain. J. Mol. Biol., 66, 181-193.
22. Ogur, M., St. John, R. and Nagai, S. (1957) Tetrazolium overlay technique for population studies of respiration deficiency in yeast. Science, 125, 928-929.
23. Povirk, L.F. and Finley, A.H.J. (1991) Genotoxicity of bleomycin. Mutat. Res., 257, 127-143.
24. Rossi, C., Poli, P., Candi, A. and Buschini, A. (1997a) Modulation of mytomycin C mutagenicity on Saccharomyces cerevisiae by glutathione, cytochrome P-450, and mitochondria interactions. Mutat. Res., 390, 113-120.
25. Rossi, C., Poli, P., Buschini, A. and Pirati, A. (1997b) Mitochondrial functionality in the metabolism of several mutagenic anticancer drugs. Mutat. Res., 379, 9.
26. Rossi, C., Poli, P., Buschini, A. and Pirati, A. (1997c) Dependence of mitoxantrone mutagenicity by glutathione and cytochrome P-450 content in respiratory proficient and deficient strains of Saccharomyces cerevisiae. Atti Associazione Genetica Italiana, 43, 201-202.
27. Russo, A., DeGraff, W., Friedman, N. and Mitchell, J.B. (1986) Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs. Cancer Res., 46, 2845-2848.
28. Shan, X., Jones, D.P., Hashni, M. and Anders, M.W. (1993) Selective depletion of mitochondrial glutathione concentrations by (R,S)-3-hydroxy-4-pentenoate potentiates oxidative cell death. Chem. Res. Toxicol., 6, 75-81.
29. Smith, B.L., Bauer, G.B. and Povirk, L.F. (1994) DNA damage induced by bleomycin, neocarzinostatin, and melphalan in a precisely positioned nucleosome. Asymmetry in protection at the periphery of nucleosome-bound DNA. J. Biol. Chem., 269, 30587-30594.
30. Stubbe, J. and Kozarich, J. (1987) Mechanisms of bleomycin-induced DNA degradation. Chem. Rev., 87, 1107-1136.
31. 5. J. Biol. Chem., 260, 4007-4015.
32. Thrall, B.D., Raha, G.A., Springer, D.L. and Meadows, G.G. (1991) Differential sensitivities of murine melanocytes and melanoma cells to buthionine sulfoximine and anticancer drugs. Pigment Cell Res., 4, 234-239.
33. van den Bogert, C., Dontje, B.H. and Kroon, A.M. (1983) Arrest of in vivo growth of a solid Leydig cell tumor by prolonged inhibition of mitochondrial protein synthesis. Cancer Res., 43, 2247-2251.
34. von Borstel, R.C. O'Connell, D.F., Mehta, R.D. and Hennig, U.G. (1985) Modulation in cytochrome P-420 and P-450 content in Saccharomyces cerevisiae according to physiological conditions and genetic background. Mutat. Res., 150, 217-224.
35. Wilkie, D., Evans, I.H., Egilsson, V., Diala, E.S. and Collier, D. (1983) Mitochondria, cell surface and carcinogenesis. Int. Rev. Cytol. Suppl. 15, 157-189.
36. Zimmermann, F.K., Kern, R. and Rasenberg, H. (1975) A yeast for simultaneous detection of induced mitotic crossing-over, mitotic gene conversion and reverse mutation. Mutat. Res., 28, 381-388.